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Abstract
The development of the human cerebral cortex is an orchestrated process involving the birth of 
neural progenitors in the peri-ventricular germinal zones, cell proliferation characterized by both 
symmetric and asymmetric mitoses, followed by migration of post-mitotic neurons to their final 
destinations in 6 highly ordered, functionally-specialized layers1,2. An understanding of the 
molecular mechanisms guiding these intricate processes is in its infancy, substantially driven by 
the discovery of rare mutations that cause malformations of cortical development (MCD)3-6. 
Mapping of disease loci in putative Mendelian forms of MCD has been hindered by marked locus 
heterogeneity, small kindred sizes and diagnostic classifications that may not reflect molecular 
pathogenesis. Here we demonstrate the use of whole-exome sequencing to overcome these 
obstacles by identifying recessive mutations in WDR62 as the cause of a wide spectrum of severe 
cerebral cortical malformations including microcephaly, pachygria with cortical thickening as well 
as hypoplasia of the corpus callosum. Some patients with WDR62 mutations had evidence of 
additional abnormalities including lissencephaly, schizencephaly, polymicrogyria and, in one 
instance, cerebellar hypoplasia, all traits traditionally regarded as distinct entities. In mouse and 
humans, WDR62 transcripts and protein are enriched in neural progenitors within the ventricular 
and subventricular zones. WDR62 expression in the neocortex is transient, spanning the period of 
embryonic neurogenesis. Unlike other known microcephaly genes, WDR62 does not apparently 
associate with centrosomes and is predominantly nuclear in localization. These findings unify 
previously disparate aspects of cerebral cortical development and highlight the utility of whole-
exome sequencing to identify disease loci in settings in which traditional methods have proved 
challenging.
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Malformations of cortical development (MCD) are a diverse group of often-devastating 
structural brain disorders reflecting deranged neuronal proliferation, migration or 
organization. Application of traditional mapping approaches have proven to be particularly 
challenging for gene discovery in MCD syndromes, where kindreds with a single affected 
member are most common, linkage studies support high locus heterogeneity, and recent 
genetic findings have fundamentally challenged prior diagnostic nosology3,7,8. Based on the 
expectation that whole exome sequencing using next generation platforms9-11 can markedly 
improve gene discovery efforts in these situations, we applied this technology to the index 
case of a small consanguineous kindred (NG 26) (Fig. 2a) from Eastern Turkey who 
presented to medical attention due to failure to reach developmental milestones and was 
found on clinical exam to have microcephaly. Neuroimaging studies identified a complex 
array of developmental abnormalities including pachygria and thickened cortex (Figs. 1a-d, 
3c and Supplementary Videos 1 and 2).
We initially performed whole genome genotyping of the two affected members to identify 
shared homozygous segments (each > 2.5 centimorgans (cM)) that together comprised 80.11 
cM (Supplementary Table 1). Given the substantial length of these shared segments, we next 
performed whole-exome sequencing of the index case using Nimblegen solid phase arrays 
and the Illumina Genome Analyzer IIx instrument9. We achieved a mean coverage of 44X 
and 94% of all targeted bases were read more than 4 times, sufficient to identify novel 
homozygous variants with high specificity (Supplementary Table 2). We identified two 
novel homozygous missense variants and one novel homozygous frameshift mutation within 
the shared homozygozity intervals (Supplementary Fig. 1 and Supplementary Table 3). The 
frameshift mutation occurred in WD repeat domain 62 (WDR62), deleting 4 base pairs in 
exon 31 (Fig. 1e). The full length WDR62 (NM_001083961) maps to chromosome 19q13.12 
and encodes 1,523 amino acids. The identified mutation causes a frameshift in codon 1,402, 
resulting in a premature stop codon at position 1,414 (Fig. 1f). The mutation was confirmed 
to be homozygous in both affected subjects and to beheterozygous in both parents using 
Sanger sequencing (Fig. 2a and Supplementary Fig. 2). It was not observed in 1,290 Turkish 
control chromosomes.
Since this homozygous mutation in WDR62 was particularly compelling, we sought to 
determine whether mutations in this gene might account for additional cases of MCD. As the 
index case was ascertained with an initial diagnosis of pachygyria, we focused on a group of 
30 probands who carried diagnoses of agyria or pachygyria and were products of 
consanguineous unions (inbreeding coefficient > 1.5%12). Among these patients, whole 
genome genotyping identified 8 with homozygosity of at least 2 cM spanning the WDR62 
locus (Supplementary Notes). One of these affected subjects, NG 891-1, was found to have 
the identical homozygous haplotype spanning the WDR62 locus and had the same 4 base 
pair deletion (Fig. 2a and Supplementary Fig. 2). Although there was no known relatedness 
between the two pedigrees, the kinship coefficient of NG 891-1 with NG 26-1 and NG 26-4 
was 5.47% and 3.72%, respectively, consistent with 4th degree relatedness (e.g. first cousins 
once removed).
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Further Sanger sequencing of the complete coding region of WDR62 in the 7 remaining 
kindreds revealed five additional novel homozygous mutations (Fig. 2b-f). The affected 
member of kindreds NG 30 and NG 294 had homozygous nonsense mutations at codons 526 
(E526X) and 470 (Q470X), respectively (Fig. 2b and d); subject NG 339-1 had a 
homozygous 17 base pair deletion leading to a frameshift at codon 1,280 that resulted in a 
premature termination codon following a novel peptide of 20 amino acids (Fig. 2e); subjects 
NG 190-1 and NG 537-1 respectively had novel homozygous missense variants W224S and 
E526K (Fig. 2c and f), which occurred at positions highly conserved among vertebrates, and 
were predicted to be deleterious by the Polyphen algorithm (Supplementary Fig.3). 
Moreover, following identification of the W224S mutation in NG 190, we ascertained two 
additional relatives affected with microcephaly and mental retardation (kinship coefficients 
of 7.47% and 5.81%) both of whom also proved to be homozygous for the same mutation. 
The resulting lod score for linkage to the trait within the expanded kindred was 3.64; the 
chromosome segment containing WDR62 was the sole homozygous region shared among all 
3 affected subjects (Supplementary Fig. 4).
All of the newly identified mutations, except E526K, were absent from 1,290 Turkish and 
1,500 Caucasian control chromosomes. The heterozygous E526K variant was detected in 3 
apparently unrelated Turkish individuals who were neurologically normal (allele frequency 
0.2%). As an additional control measure in the evaluation of these homozygous mutations, 
we sequenced the coding region of the gene in 12 consanguineous patients with non-
neurological conditions who were found to have segments of homozygosity of at least 1 
million base pairs spanning WDR62. None of these 12 individuals had protein coding 
changes in WDR62 (data not shown). Similarly, we identified only four heterozygous novel 
missense variants in WDR62 in the sequence of 100 whole exomes of subjects with non-
neurological diseases (Supplementary Table 4). Public databases (dbSNP) showed no 
validated nonsense or frameshift alleles at this locus. Finally, we have not observed any 
copy number variants (CNVs) overlapping the coding regions of WDR62 in our own set of 
11,320 whole genome genotypes (data not shown) and only one deletion identified by BAC 
array is reported in the Database of Genomic Variants (http://projects.tcag.ca/variation/).
All of the index cases with WDR62 mutations presented to medical attention with mental 
retardation and were found to have prominent microcephaly on physical exam; some also 
suffered from seizures (Supplementary Notes). Re-examination of the high field strength (3 
Tesla) magnetic resonance imaging (MRI) scans of the affected subjects by independent 
neuroradiologists blinded to prior diagnoses identified hallmarks of a wide range of severe 
cortical malformations (summarized in Supplementary Table 5 and shown in Supplementary 
Videos). All 9 patients had extreme microcephaly, pachygyria and hypoplasia of the corpus 
callosum (Fig. 3). In addition, they demonstrated radiographic features consistent with 
lissencephaly, including varying degrees of cortical thickening and loss of gray-white 
junction (Fig. 3). Underopercularization (shallow Sylvian fissures) (Fig. 1b) was observed in 
6 affected subjects. Two of the subjects had striking polymicrogyria that predominantly 
affected one hemisphere (Fig. 3c, d and g); in one this was associated with a unilateral open-
lip schizencephaly characterized by a cleft surrounded by gray matter that extended into the 
ventricle (Fig. 3d and g). Other malformations observed included hippocampal 
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dysmorphology with vertical orientation in 6 cases and a single case of unilateral dysgenesis 
of the cerebellum (Fig. 3f). There were no abnormalities of the brainstem with the exception 
of unilateral atrophy observed in one patient, most likely secondary to Wallerian 
degeneration from the severe cerebral abnormalities observed (Fig. 3h).
Given the wide range of cortical malformations associated with WDR62 mutations, we next 
investigated its expression in the developing mouse brain. Notably, during early 
development, in whole-mount embryos from E9.5 to E11.5, Wdr62 expression is prominent 
in neural crest lineages (Supplementary Fig. 5a-c). Wdr62 also shows striking expression in 
the ventricular and subventricular zones (VZ and SVZ, respectively) during the period of 
cerebral cortical neurogenesis (embryonic days 11.5 to 16.5), with expression decreasing in 
intensity by E17.5 (Fig. 4a and data not shown). In the cerebellum, Wdr62 is strongly 
expressed in precursors of granule neurons (GNPs) at late embryonic and early postnatal 
stages and by postnatal day 9 (P9), Wdr62 expression is dramatically reduced 
(Supplementary Fig. 5g and h). By postnatal day 21 (P21), low levels of Wdr62 expression 
are detected only in the hippocampus and the piriform cortex and transcription is absent 
among differentiated cortical neurons (Supplementary Fig. 5i).
We next examined WDR62 protein expression using a previously characterized antibody13 
(Fig. 4b-d). Both in the mouse and human fetal brain, WDR62 was enriched within the VZ 
and SVZ, consistent with our in-situ hybridization findings (Fig. 4 and Supplementary 
Figure 6). These stainings suggested that WDR62 localizes predominantly to the nucleus in 
neuronal cells, which we confirmed by immunofluorescence microscopy using cell cultures 
and western blotting with sub-cellular fractionation of cortical embryonic mouse cells with a 
second antibody (Fig. 4e and Supplementary Fig. 7). Genes previously implicated in 
microcephaly encode centrosomal proteins14-16, thus it is noteworthy that WDR62 is 
apparently not associated with the centrosome during mitosis (Supplementary Fig. 8).
Our findings implicate WDR62 in the pathogenesis of a spectrum of cortical abnormalities 
that heretofore have largely been conceptualized to be distinct3,7,8, suggesting that these 
diverse features can have unified underlying causation. It is noteworthy that WDR62 lies in a 
10 million base pair interval that had previously been identified as a microcephaly locus, 
MCPH217. Although there was no imaging studies presented in the prior mapping of this 
locus, our findings suggest that WDR62 is the MCPH2 gene and extend the phenotype 
beyond microcephaly.
To seek further insight into the biological function of WDR62, we examined expression data 
of early embryonic development of mouse brain (GSE8091)18 for genes with expression 
profiles significantly correlated with that of WDR62 (Bonferroni corrected P < 0.01, 
n=1,104). Functional annotation suggested that positively correlated genes were enriched for 
those encoding nuclear proteins (Benjamini adjusted P = 6.23 ×10−30), RNA processing 
proteins (Benjamini adjusted P = 1.90 ×10−31) and cell cycle proteins (Benjamini adjusted P 
= 3.25 ×10−18). Negatively correlated genes encoded neuronal differentiation proteins 
(Benjamini adjusted P = 1.40 ×10−7). Several genes linked to developmental brain 
malformations, such as DCX, DCC, and BURB1B, are found in these enrichment sets 
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(Supplementary Table 6). Further work will be required to extend these expression findings 
and clarify the normal role of WDR62.
To date, whole exome sequencing has led to the identification of a single new Mendelian 
locus for a genetically homogeneous condition10. Our results demonstrate that this 
technology will be particularly valuable for gene discovery in those conditions in which 
mapping has been confounded by locus heterogeneity and uncertainty regarding the 
boundaries of diagnostic classification, pointing to a very bright future for its broad 
application to medicine.
Methods Summary
Human Subjects
The study protocol was approved by the Yale Human Investigation Committee. Institutional 
review board approvals for genetic studies, along with written consent from all study 
subjects, were obtained at the participating institutions (see Supplementary Notes).
Targeted Exome Sequencing
Genomic DNA of sample NG 26-1 was captured on a NimbleGen 2.1M human exome array 
with modifications to the manufacturer’s protocol9, followed by single-read cluster 
generation on the Cluster Station (Illumina, San Diego, CA, USA). The captured, purified, 
and clonally amplified library targeting the exome from patient NG 26-1 was then 
sequenced on Genome Analyzer IIx. Two lanes of single-read sequencing at a read length of 
74 base pairs was performed following the manufacturer’s protocol.
Exome Sequence Analysis
The sequence reads obtained were aligned to the human genome (hg18) using Maq 19and 
BWA 20 software. The percent alignment of the reads to both the reference genome as well 
as the targeted region, exome, was calculated using perl scripts9. Similarly, perl scripts were 
used for the detection of mismatch frequencies and error positions. SAMtools 21 was used 
for the detection of single nucleotide variations on the reads aligned with Maq. The indels 
were detected on the reads aligned with BWA for its ability to allow for gaps during the 
alignment. Shared homozygous segments of the affected individuals were detected using 
Plink software version 1.0612, and the variants were filtered for shared homozygosity. The 
variants were annotated for novelty with comparison to both dbSNP (build 130) and nine 
personal genome databases and previous exome sequencing experiments performed by our 
human genomics group. Novel variants were further evaluated for their impact on the 
encoded protein, conservation across 44 vertebrate species and C. elegans and D. 
melanogaster, expression patterns and potential overlap with known miRNAs.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1. Identification of a 4 base pair deletion in the WDR62 gene in a family with microcephaly 
and pachygria
a-d, Coronal (a) and axial (c) MR images of a control subject as compared to NG 26-1 (b, d) 
confirms the clinical diagnosis of microcephaly and shows a diffusely thickened cortex, an 
indistinct gray-white junction, pachgyria and underoperculization. All images are T2 
weighted (photographically inverted). Scale bars in centimeters are shown. e, A four base-
pair deletion (red box) in the WDR62 is identified through exome sequencing (WT: wild 
type). f, Sanger sequencing confirms the deleted bases (in green). The altered amino acid 
sequence (starting at position 1402) leading to a premature stop-codon (X) is shown in red.
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Fig. 2. Additional WDR62 mutations
a-f, Pedigree structures along with mutated bases (red) and the corresponding normal alleles 
(green) are marked on the chromatograms (mutant–left; wild type-right). a, Families NG 26 
and 891 harbor the identical 4 base pair deletion, whereas nonsense mutations leading to 
premature stop codons (X) are observed in NG 30 (b) and NG 294 (d). Missense mutations 
affecting conserved amino acids are seen in NG 190 (c) and NG 537 (f). In NG 339 (e), a 17 
base pair deletion leads to a premature stop codon. (g) The locations of independent 
mutations are indicated on the genomic organization of WDR62.
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Fig. 3. Representative MRI images from patients demonstrating the wide spectrum of findings 
associated with mutations in WDR62
a, e, i, k, Axial (a), coronal (e), sagittal (k) MRI images and three-dimensional (3D) surface 
rendering (i) of a control subject are shown. b, Microlissencephalic features with 
microcephaly, diffusely thickened cortex, loss of gray-white junction and pachygyria. c, 
Asymmetric microcephalic hemispheres with marked polymicrogyria (arrowheads). d, 
Significant polymicrogyria (black arrowheads) and open-lip schizencephaly (red 
arrowhead). f, Unilateral cerebellar hypoplasia (arrowhead). g, Open-lip schizencephaly (red 
arrowhead) and the polymicrogyric cortex. h, Unilateral brain stem atrophy (arrow). j, 3D 
surface rendering demonstrating craniofacial dysmorphology. l, Microcephaly, pachygyria 
and abnormally shaped corpus callosum (arrowheads).
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Fig 4. Wdr62 expression in the developing mouse brain
a, Wdr62 expression is enriched in the VZ and SVZ as seen with in-situ hybridization. b, 
WDR62 protein(red) distribution reveals a similar pattern. c, d, WDR62 (red) localizes to 
the nuclei and is expressed by neural stem cells and intermediate progenitors, as marked by 
SOX2 and TBR2 expression (green), respectively. e, Immunofluorescent staining for α-
tubulin (cytoplasmic, blue), S0X2 (nuclear, green) and WDR62 (red) in E12.5 cortical 
neural progenitor cells reveals that the distribution of the WDR62 overlaps with that of 
SOX2 and is predominantly nuclear. (Nuclear staining by DAPI (blue) in b-d; Right most 
panels are composite images in b-e).
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